Abdel-Halim M N, Farah S I
Comp Biochem Physiol B. 1985;81(1):9-19. doi: 10.1016/0305-0491(85)90156-7.
Acetyl CoA carboxylase, the rate-limiting enzyme in regulating fatty acid synthesis, is thought to be controlled by allosteric effectors, its state of aggregation, covalent modulation and protein inhibitors. It is still obscure whether citrate, a positive allosteric effector, and long-chain fatty acyl CoA esters, negative allosteric effectors, function physiologically to regulate acetyl CoA carboxylase activity. New evidence from several laboratories reveals that the covalent phosphorylation may not involve regulation of acetyl CoA carboxylase activity. Protein inhibitors from liver cytosol and a peptide from fat cells were found to regulate acetyl CoA carboxylase both in vivo and in vitro. Coenzyme A, guanosine 5-monophosphate and phosphatidylinositol 4,5-bisphosphate may have an indirect effect, but certainly no direct involvement, on carboxylase activity.
乙酰辅酶A羧化酶是调节脂肪酸合成的限速酶,被认为受变构效应物、其聚合状态、共价修饰和蛋白质抑制剂的控制。柠檬酸(一种正变构效应物)和长链脂肪酰辅酶A酯(负变构效应物)是否在生理上调节乙酰辅酶A羧化酶的活性仍不清楚。来自几个实验室的新证据表明,共价磷酸化可能不参与乙酰辅酶A羧化酶活性的调节。已发现来自肝细胞溶质的蛋白质抑制剂和来自脂肪细胞的一种肽在体内和体外均能调节乙酰辅酶A羧化酶。辅酶A、鸟苷5-单磷酸和磷脂酰肌醇4,5-二磷酸可能对羧化酶活性有间接影响,但肯定没有直接参与。